company background image

Everest Medicines SEHK:1952 Stock Report

Last Price


Market Cap







01 Apr, 2023


Company Financials +

1952 Stock Overview

About the company

Everest Medicines Limited, a biopharmaceutical company, engages in discovery, licensing, clinical development, and commercialization of therapies to address critical unmet medical needs in Greater China and other Asia Pacific markets. Its pipeline products include eleven clinical-stage drug candidates for the treatment of oncology, immunology, cardio-renal, and infectious diseases. Everest Medicines Limited was incorporated in 2017 and is headquartered in Shanghai, China.

Snowflake Analysis

1952 fundamental analysis
Snowflake Score
Future Growth5/6
Past Performance0/6
Financial Health4/6

My Notes

Capture your thoughts, links and company narrative

Everest Medicines Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Everest Medicines
Historical stock prices
Current Share PriceHK$15.44
52 Week HighHK$30.50
52 Week LowHK$5.98
1 Month Change-15.54%
3 Month Change-11.16%
1 Year Change-32.43%
3 Year Changen/a
5 Year Changen/a
Change since IPO-78.78%

Recent News & Updates

Recent updates

A Look At The Fair Value Of Everest Medicines Limited (HKG:1952)

Sep 26
A Look At The Fair Value Of Everest Medicines Limited (HKG:1952)

Shareholder Returns

1952HK BiotechsHK Market

Return vs Industry: 1952 underperformed the Hong Kong Biotechs industry which returned -10% over the past year.

Return vs Market: 1952 underperformed the Hong Kong Market which returned -8% over the past year.

Price Volatility

Is 1952's price volatile compared to industry and market?
1952 volatility
1952 Average Weekly Movement15.8%
Biotechs Industry Average Movement8.8%
Market Average Movement6.9%
10% most volatile stocks in HK Market13.8%
10% least volatile stocks in HK Market3.4%

Stable Share Price: 1952 is more volatile than 90% of Hong Kong stocks over the past 3 months, typically moving +/- 16% a week.

Volatility Over Time: 1952's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of Hong Kong stocks.

Everest Medicines Limited Fundamentals Summary

How do Everest Medicines's earnings and revenue compare to its market cap?
1952 fundamental statistics
Market CapHK$4.79b
Earnings (TTM)-HK$282.66m
Revenue (TTM)HK$14.62m


P/S Ratio


P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
1952 income statement (TTM)
Cost of RevenueCN¥4.65m
Gross ProfitCN¥8.15m
Other ExpensesCN¥255.43m

Last Reported Earnings

Dec 31, 2022

Next Earnings Date


Earnings per share (EPS)-0.80
Gross Margin63.69%
Net Profit Margin-1,933.11%
Debt/Equity Ratio0.5%

How did 1952 perform over the long term?

See historical performance and comparison